Overview

Innovative Treatments in Pneumonia (ITIP) 3

Status:
Completed
Trial end date:
2018-07-01
Target enrollment:
Participant gender:
Summary
This is a prospective observational study assessing the clinical outcomes of children 2 to 59 months of age with both pneumonia and other co-morbidities presenting to a tertiary hospital outpatient setting in Malawi, Africa who are most at risk for mortality or have other complications and thus, are typically excluded from childhood pneumonia studies.
Details
Lead Sponsor:
Save the Children
Collaborators:
College of Medicine at the University of Malawi
Kamuzu Central Hospital
University of Malawi College of Medicine
University of North Carolina
University of North Carolina, Project Lilongwe Medical Relief Trust Fund
University of Washington
Treatments:
Amoxicillin
Ampicillin
Gentamicins
Penicillins